Business Trends– category –
-
Perovskite Stock Watch 2026: Sekisui Chemical Targets 100MW Line by 2027, Oxford PV Begins Commercial Shipments in Sept 2024, Hanwha Solutions Achieves IEC/UL Certification for Tandem Tech
Exoswan Insights Global Overview The perovskite sector is seeing significant commercialization strides in 2026. Japan's Sekisui Chemical aims to launch a 100MW roll-to-roll production line by 2027, scaling to GW capacity by 2030. Oxford ... -
Kyoto University Spinoff EneCoat Achieves Over 30% Tandem Cell Efficiency with Toyota, Aims for 200-300 MW Production by 2030
Perovskite-Info Japan Overview EneCoat Technologies, a Kyoto University spinoff, has achieved over 30% power conversion efficiency in perovskite/silicon 4-terminal tandem cells in collaboration with Toyota Motor Corporation. The company ... -
Dexcom Gains FDA Clearance for G7 15-Day CGM and Smart Basal, Joins TEMPO Pilot Program
Simply Wall St USA Overview Dexcom has secured FDA clearance for its Dexcom G7 15-Day continuous glucose monitoring (CGM) system, extending wear time to 15.5 days for all types of adult diabetes patients. Simultaneously, Dexcom Smart Bas... -
Rakovina Therapeutics Advances AI Cancer Drug Pipeline with NanoPalm Joint Venture, Nano-Lipid Formulation Data Public Release a 2026 Milestone
Streetwise Reports USA Overview Rakovina Therapeutics is advancing its AI cancer drug pipeline through a proposed joint venture with NanoPalm, combining Rakovina's AI drug discovery capabilities with NanoPalm's self-targeting patterned l... -
Nano One Announces Licensing Strategy to Meet LFP Cathode Active Material Demand Outside China, Operates 200 t/year Pilot Line
Energy-Storage.News Canada Overview Nano One, a lithium-ion battery cathode materials producer, announced a strategy to address the growing demand for LFP cathode active materials outside China, focusing on a license-based approach throu... -
Nanoparticle-Based Drug Delivery Proven Clinically Feasible for Cancer and Genetic Disorders, Highlighted by Doxil® Success
MDPI Switzerland Overview Nanoparticle-based drug delivery systems have achieved clinical success in multiple oncological and genetic disorder indications, demonstrating their translational potential. Doxil® (liposomal doxorubicin), FDA-... -
IQE Secures Purchase Agreement with Quintessent for Quantum Dot Laser Epitaxy for AI Data Centers, Advancing to Customer Sampling
IQE UK Overview IQE plc has announced a purchase agreement with Quintessent Inc., an innovator of resilient, low-cost connectivity solutions for AI data centers, for the supply of quantum dot laser (QDL) epitaxy. This agreement will see ... -
Sparc Technologies Completes First Commercial Delivery of ecosparc® Graphene Additive for High-Performance Coatings, Partnering with AkzoNobel
Graphene-info.com Australia Overview Sparc Technologies has completed its first commercial delivery of 'ecosparc®' graphene additive to a Tier 1 coatings customer, fulfilling a 160kg order for high-performance protective coatings from it... -
DNP Unveils Energy-Efficient 10nm Nanoimprint Lithography for 1.4nm Logic Chips, Targeting 2027 Mass Production
Taiwan News Japan Overview Dai Nippon Printing (DNP) has announced a significant advancement in semiconductor manufacturing with its 10nm linewidth nanoimprint lithography (NIL) template, designed for 1.4nm-class logic semiconductors. Th... -
Evonik Invests Over C$150 Million in Vancouver LNP Drug Manufacturing Facility, Targeting Late 2029 Launch
Pharmaceutical Outsourcing Canada Overview Evonik is investing over C$150 million (approximately US$110 million) to significantly expand its lipid formulation and lipid nanoparticle (LNP) drug product manufacturing capabilities in Vancou...
